Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosutinib + Exemestane in Advanced Breast Cancer
NCT00793546Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Feb 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of bosutinib in breast cancer, sponsored by Pfizer. Started Feb 2009; status: terminated.
02
Drugs
bosutinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00793546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00793546.